DANA RAE: Open Payments
NPI 1972138741 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 35 payments from 9 companies in 2025. Trend: 2023 $686 · 2024 $450 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $204 |
| Aimmune Therapeutics, Inc. | 19 | $159 |
| PFIZER INC. | 4 | $78 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Exact Sciences Corporation | 2 | $32 |
| Edwards Lifesciences Corporation | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $15 |
Products named: FARXIGA, ZENPEP, PREVNAR 20, SHINGRIX, AIRSUPRA, SAPIEN 3 Ultra RESILIA, REXULTI, ZAVZPRET.
Industry payments across AZ — which companies pay providers there.
